News Focus
News Focus
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 9445

Saturday, 10/06/2012 2:04:29 PM

Saturday, October 06, 2012 2:04:29 PM

Post# of 20689
Research report on RA states what many investor already knew:

http://finance.yahoo.com/news/rheumatologists-continue-prefer-enbrel-humira-130000072.html

Rheumatologists Continue to Prefer Enbrel and Humira as Both Their First and Second Line Biologic Agents and the Combined Formulations of Orencia as the Dominant Third Line Agent

Save yourself the money and don’t buy the report!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”